BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bdb 1 1 Adamantylcarbonyl 4 2 4 Dichlorophenyl Phenyl Methyl Piperazine Chembl109569

2+ PubMed studies analyzed · Evidence Score: 5.8

Research Domains

Bdb 1 1 Adamantylcarbonyl 4 2 4 Dichlorophenyl Phenyl Methyl Piperazine Chembl109569 has been studied across 1 research domains including 🧠 Focus & Attention. The primary research focus is 🧠 Focus & Attention with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bdb 1 1 Adamantylcarbonyl 4 2 4 Dichlorophenyl Phenyl Methyl Piperazine Chembl109569, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

taranabant
2 shared targets
rimonabant
2 shared targets
2
2 shared targets
cp
2 shared targets
magnolol
2 shared targets
anandamide
2 shared targets
honokiol
2 shared targets
delta9
2 shared targets
cannabinol
2 shared targets
cannabichromene
2 shared targets
Loading evidence profile...

This evidence profile for Bdb 1 1 Adamantylcarbonyl 4 2 4 Dichlorophenyl Phenyl Methyl Piperazine Chembl109569 is generated deterministically from 2 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.